{
  "id": 18285181,
  "title": "SFC Capital backs Nayara's AI platform for patient care",
  "url": "https://urgent.news/2026/11/05/sfc-capital-backs-nayaras-ai-platform-for-patient-care",
  "topic": "ai",
  "section": "AI",
  "published": "2026-11-05T10:00:00.000Z",
  "source": {
    "name": "Tech.eu",
    "slug": "tech-eu",
    "url": "https://tech.eu/2026/11/05/sfc-capital-backs-nayaras-ai-platform-for-patient-care/"
  },
  "original_language": "en",
  "account": "UK-based AI healthcare company Nayara has secured pre-seed funding from SFC Capital, an early-stage investor in the UK. This investment will enable Nayara to develop and expand its AI-powered platform aimed at enhancing patient communication and support between clinical appointments. Nayara creates AI companions for hospitals, healthcare systems, and medical technology firms, offering personalized guidance and aiding healthcare professionals in staying informed about patients' requirements outside clinical environments.\n\nPatients frequently encounter medical inquiries, uncertainty, and concerns between appointments, but healthcare often transpires beyond hospital walls. During these intervals, patients may face unanswered medical questions, and clinical teams grapple with routine inquiries alongside their regular duties, all while lacking real-time visibility into patients' progress between visits. Nayara aims to tackle these issues through AI-powered companions that can handle routine questions, provide tailored guidance and emotional support, and proactively check in with patients. The platform can also identify concerns and requests necessitating attention from healthcare providers and forward them to the appropriate teams.\n\nNayara's objective is to streamline routine communication and offer insights into patients' needs, thereby reducing administrative burdens and assisting healthcare professionals in prioritizing follow-up care. According to Gal Moore, co-founder and CEO of Nayara, while medical technology has advanced, patient support has not evolved at the same rate. Nayara was founded on the belief that no patient should ever feel isolated in their healthcare journey, and no warning sign should go unaddressed due to the clinical team's lack of information or time to act.\n\nThe company's strategy integrates insights from medical professionals, patients, individuals with experience supporting loved ones through illness, and AI engineers. These diverse perspectives inform the development of Nayara's platform. Nayara's technology is already operational in various clinical pathways, such as oncology, where its AI companion for breast cancer patients has aided hundreds of individuals. The newly acquired funding will be employed to expedite product development, facilitate clinical validation, and bolster Nayara's commercial endeavors.",
  "summary": "UK-basedhealthcare AI company Nayara has closed a pre-seed funding round led by SFC Capital, an early-stage investor in the UK. The funding will support thedevelopment and expansion of its AI-powered ...",
  "key_points": [
    "UK-based AI healthcare company Nayara secures pre-seed funding from SFC Capital.",
    "Platform aims to enhance patient communication and support between clinical appointments.",
    "Funding will accelerate product development and clinical validation."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}